Scaling from the lab bench to full-scale manufacturing is one of the most exciting and most challenging stages for diagnostic developers. You have validated your assay in R&D, the results…

In the fast-paced world of in-vitro diagnostics (IVD), access to biologically relevant and functionally validated proteins can make or break assay performance. At Denovo Biolabs, we recognize this need and supply researchers and…

With rising global incidence of autoimmune conditions and biologic therapeutics, demand for cytokine-based diagnostics is accelerating. Recombinant TNF alpha sits at the center of this transformation. Enabling faster, more reliable diagnostics and therapeutic…

Therapeutic antibodies like Nivolumab have revolutionized cancer care, offering new hope to patients across the globe. However, the success of these therapies heavily depends on accurate pharmacokinetic (PK) monitoring and that…

Dengue remains a pressing global health challenge, especially in tropical and subtropical regions like India, Southeast Asia, and South America. With rising caseloads and overlapping symptoms with Zika, Chikungunya and…

Chikungunya virus (CHIKV) continues to be a public health challenge across Asia, Africa and Latin America. Yet, despite its widespread impact, reliable, sensitive and scalable diagnostics for Chikungunya remain limited,…

In the world of biosimilars, diagnostics, and regulated bioanalytics, an ELISA kit is only as useful as its validation. Yet many teams underestimate the complexity of taking a good-looking ELISA curve…

A CRO’s Guide to Smarter Scientific Scale-Up In today’s fast-paced biotech and diagnostics landscape, antibody development is not just a lab function — it is a strategic decision. For startups,…

India is rapidly emerging as a global player in biopharmaceutical innovation, diagnostics, and vaccine manufacturing. Yet, amid this growth lies a quiet but critical bottleneck: our dependency on imported biological reagents. From…

Chinese Hamster Ovary (CHO) cells are the backbone of modern biologics manufacturing, producing most therapeutic antibodies and recombinant proteins. During CHO-based production, host cell proteins (HCPs) – native CHO proteins – inevitably…

When you are developing a biosimilar, designing an assay, or characterizing a biologic, the antibody you use is not just a tool, it is the foundation of your data. While…

In the complex world of drug discovery, every interaction matters. Whether it is a small molecule binding to a receptor, or an antibody interacting with its antigen, understanding these interactions…